Close Menu

The Washington Post's Christopher Weaver says that, "over the past two decades, venture capitalists helped make possible striking advances in health care, including robotic surgery, cancer vaccines, and genomics." But US healthcare spending is "forecasted to grow in an unaffordable way for the country," says John Doerr from Kleiner Perkins Caufield & Byers -- a situation making more VCs focus on supporting companies that could help cut those costs, according to Weaver.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.